| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner
6 companies
General Atlantic, L.P. is Director, 10% Owner at ALKT and has filed Form 4s across 6 companies.
Historically, General Atlantic, L.P.'s trades have earned a strong insider score of 70/100 across 34 rated trades. Over a 12-month horizon, 69.6% of those trades were profitable, with an average 12-month return of +26.6%.
The biggest single holding is ALKT (~$506.3M) as Director, 10% Owner. The ALKT filings lean toward selling, a net 300,768 shares.
General Atlantic, L.P. has 36 Form 4 filings on record from January 2015 to May 2026, across 6 companies: Director, 10% Owner at Alkami Technology (ALKT), 2021–2026; 10% Owner at Alignment Healthcare (ALHC), 2021–2025; 10% Owner at Clear Secure (YOU), 2021–2023, and 3 more.
The 76 reported transactions were 25 open-market sales, 16 other transactions, 15 open-market purchases and 10 conversions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 5 purchases worth about $157.0M and 25 sales worth about $2.0B.
The largest open-market purchase was 2,846,015 shares of ALKT at an average $17.77 on March 11, 2026, about $50.6M.
The largest open-market sale was 17,000,000 shares of ALHC at an average $15.28 on May 19, 2025, about $259.8M. Twelve months later ALHC was up 1%.
None of the 9 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | ALKT Alkami Technology, Inc. | Director, 10% Owner | Buy | 1,975,000 | $16.67 | $32,929,750.00 | +5.5% | +21.6% | - | |
| May 6, 2026 | ALKT Alkami Technology, Inc. | Director, 10% Owner | Buy | 2,066,543 | $16.77 | $34,664,923.68 | +13.4% | +12.9% | - | |
| Mar 12, 2026 | ALKT Alkami Technology, Inc. | Director, 10% Owner | Buy | 500,000 | $18.33 | $9,165,000.00 | +3.4% | -16.9% | - | |
| Mar 11, 2026 | ALKT Alkami Technology, Inc. | Director, 10% Owner | Buy | 2,846,015 | $17.77 | $50,564,147.54 | +23.7% | -17.6% | - | |
| Dec 12, 2025 | ALHC Alignment Healthcare, Inc. | 10% Owner | Sell | 11,119,494 | $18.57 | $206,489,003.58 | -45.2% | -11.6% | - | |
| Sep 17, 2025 | ALHC Alignment Healthcare, Inc. | Director, 10% Owner | Sell | 6,246,096 | $16.01 | $99,999,996.96 | -20.3% | +20.1% | -47.8% | |
| Sep 12, 2025 | ALHC Alignment Healthcare, Inc. | Director, 10% Owner | Sell | 13,460,000 | $16.01 | $215,494,600.00 | -30.4% | +21.0% | -21.4% | |
| Aug 13, 2025 | ALKT Alkami Technology, Inc. | Director, 10% Owner | Buy | 1,396,162 | $21.26 | $29,688,381.60 | +13.1% | -10.1% | -8.0% | |
| May 19, 2025 | ALHC Alignment Healthcare, Inc. | Director, 10% Owner | Sell | 17,000,000 | $15.28 | $259,760,000.00 | -27.7% | -5.8% | +0.7% | |
| Nov 25, 2024 | ALKT Alkami Technology, Inc. | Director, 10% Owner | Sell | 3,000,000 | $39.75 | $119,250,000.00 | -23.7% | -28.8% | -48.9% |